Blogs
Great ideas often come from a great conversation. Browse through the latest blogs from Talking Medicines.
Blog Posts
All Blog Posts
See More →
Blog Categories
All Blogs
Bridging Two Worlds: Entrepreneurial Lessons from Silicon Valley and Scotland
Written by Jo Halliday, CEO, Talking Medicines After spending the past three weeks in Silicon Valley, at Talking Medicines we have been struck by the stark differences—and surprising...
Navigating the EU AI Act: How the AI Pact Supports Businesses in Compliance and Innovation
The European Commission has launched the EU AI Act, the first comprehensive regulation governing artificial intelligence (AI) in the world. As of 02 February 2025, businesses are facing a crucial...
Beyond Boundaries: Scaling, Collaboration, and Gender Diversity in Leadership
Building a successful business in today’s fast-paced world requires vision, strategy, and the right support at every stage of growth. At Talking Medicines, we are embracing opportunities to scale...
Talking Medicines West Coast US Expansion
Written by Jo Halliday, CEO, Talking Medicines Talking Medicines has taken a high-profile residency in Silicon Valley as part of the Scottish Government/SDI Market Booster Program, marking a...
The Future of AI in Pharma Marketing: How Human Insight and AI Can Work Together
More than 80% of industry experts are already incorporating AI into their strategies, according to research by and for good reason. AI-driven insights are enabling better decision-making, improving...
How AI in Pharma Marketing is Transforming Rare Disease Audience Insights
Rare disease communities face unique challenges that extend beyond patient care—challenges that are often overlooked in broader health strategies. With over 7,000 rare diseases affecting small,...
Decoding Unstructured Data: AI in HCP & Patient Analytics
In Healthcare Marketing, understanding the nuanced perspectives of both Healthcare Professionals (HCPs) and Patients is critical. Whether you’re managing the launch of a new drug or supporting...
How Cutting-Edge Technology is Making AI Smarter and Affordable
Written by, Elizabeth Fairley, COO & CDO at Talking Medicines With NVIDIA losing over $600 billion in market value today, the focus is all on what caused it—DeepSeek AI. Before jumping to...
Securing the Future: AI and Data Privacy in HCP & Patient Analytics
As Artificial Intelligence (AI) becomes increasingly indispensable in Healthcare Professional (HCP) targeting and engagement, it is reshaping the landscape of Healthcare Marketing. A recent survey...
Talking Medicines Joins Silicon Valley Market Booster to Accelerate US Growth
AI-Powered Conversational Data Intelligence for Healthcare Marketing Talking Medicines, a trailblazing company based in Glasgow, Scotland, is revolutionizing healthcare marketing with its...
5 AI Trends Driving Healthcare Marketing in 2025
As we move through 2025, AI technologies continue to shape Healthcare Marketing strategies. With AI offering solutions to enhance operational efficiency, improve accuracy, and deliver personalized...
The Impact of AI in HCP Analytics
The Impact of AI in HCP Analytics Healthcare Professionals (HCPs) are continuously engaged in a variety of discussions—whether at conferences, within community forums, or through social media...